相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combined treatment with niclosamide ethanolamine and artemether combination improves type 1 diabetes via the targeting of liver mitochondria
Wenci Weng et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2022)
Niclosamide Ethanolamine Salt Alleviates Idiopathic Pulmonary Fibrosis by Modulating the PI3K-mTORC1 Pathway
Xiaolin Pei et al.
CELLS (2022)
Niclosamide-A promising treatment for COVID-19
Shivani Singh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2022)
Molecular interactions of niclosamide with hydroxyethyl cellulose in binary and ternary amorphous solid dispersions for synergistic enhancement of water solubility and oral pharmacokinetics in rats
Jigar S. Bhanushali et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2022)
Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs
Shawn Herring et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
A High-Content Screen Identifies Drugs That Restrict Tumor Cell Extravasation across the Endothelial Barrier
Georg Hilfenhaus et al.
CANCER RESEARCH (2021)
Combined chemotherapy for triple negative breast cancer treatment by paclitaxel and niclosamide nanocrystals loaded thermosensitive hydrogel
Deqian Zhao et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Discovery of a Small Molecule Inhibitor of Human Adenovirus Capable of Preventing Escape from the Endosome
Jimin Xu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Development and evaluation of inhalable composite niclosamide-lysozyme particles: A broad-spectrum, patient-adaptable treatment for coronavirus infections and sequalae
Ashlee D. Brunaugh et al.
PLOS ONE (2021)
Targeting Cancer Stem Cells with Repurposed Drugs to Improve Current Therapies
Dunne Fong et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2021)
Phase Ib trial of reformulated niclosamide with abiraterone/prednisone in men with castration-resistant prostate cancer
Mamta Parikh et al.
SCIENTIFIC REPORTS (2021)
Bioanalysis of niclosamide in plasma using liquid chromatography-tandem mass and application to pharmacokinetics in rats and dogs
Hae-In Choi et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2021)
Anthelminthic niclosamide inhibits tumor growth and invasion in cisplatin-resistant human epidermal growth factor receptor 2-positive breast cancer
Junjun Liu et al.
ONCOLOGY LETTERS (2021)
A Synergistic Combination of Niclosamide and Doxorubicin as an Efficacious Therapy for All Clinical Subtypes of Breast Cancer
Garima Lohiya et al.
CANCERS (2021)
Metformin and Niclosamide Synergistically Suppress Wnt and YAP in APC-Mutated Colorectal Cancer
Hee Eun Kang et al.
CANCERS (2021)
Niclosamide and Pyrvinium Are Both Potential Therapeutics for Osteosarcoma, Inhibiting Wnt-Axin2-Snail Cascade
Young Yi et al.
CANCERS (2021)
Repurposing Niclosamide for Targeting Pancreatic Cancer by Inhibiting Hh/Gli Non-Canonical Axis of Gsk3β
Jyoti B. Kaushal et al.
CANCERS (2021)
An update of anti-viral treatment of COVID-19
Serap Simsek Yavuz et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2021)
Effects of salinomycin and niclosamide on small cell lung cancer and small cell lung cancer circulating tumor cell lines
Maximilian Hochmair et al.
INVESTIGATIONAL NEW DRUGS (2020)
Injectable pegylated niclosamide (polyethylene glycol-modified niclosamide) for cancer therapy
Rui Ma et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2020)
Structure-Activity Relationship Studies on Diversified Salicylamide Derivatives as Potent Inhibitors of Human Adenovirus Infection
Jimin Xu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential
Jimin Xu et al.
ACS INFECTIOUS DISEASES (2020)
Preclinical Testing of a Novel Niclosamide Stearate Prodrug Therapeutic (NSPT) Shows Efficacy Against Osteosarcoma
Gireesh B. Reddy et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Local Mitochondrial ATP Production Regulates Endothelial Fatty Acid Uptake and Transport
Ayon Ibrahim et al.
CELL METABOLISM (2020)
Niclosamide and its derivative DK-520 inhibit RANKL-induced osteoclastogenesis
Yurui Jiao et al.
FEBS OPEN BIO (2020)
Preparation and in vitro antitumor effects on MDA-MB-231 cells of niclosamide nanocrystals stabilized by poloxamer188 and PBS
Qiang Fu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Autophagy-Inducing Inhalable Co-crystal Formulation of Niclosamide-Nicotinamide for Lung Cancer Therapy
Eupa Ray et al.
AAPS PHARMSCITECH (2020)
JMX0207, a Niclosamide Derivative with Improved Pharmacokinetics, Suppresses Zika Virus Infection Both In Vitro and In Vivo
Zhong Li et al.
ACS INFECTIOUS DISEASES (2020)
FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2
Ahmed Mostafa et al.
PHARMACEUTICALS (2020)
Drug Resistance in Cancer Therapy and the Role of Epigenetics
Takeshi Asano
JOURNAL OF NIPPON MEDICAL SCHOOL (2020)
Noncanonical pS727 post translational modification dictates major STAT3 activation and downstream functions in breast cancer
Shalini Dimri et al.
EXPERIMENTAL CELL RESEARCH (2020)
Mitochondria-centric bioenergetic characteristics in cancer stem-like cells
Min-Kyue Shin et al.
ARCHIVES OF PHARMACAL RESEARCH (2019)
New insights into niclosamide action: autophagy activation in colorectal cancer
Phillip T. Newton
BIOCHEMICAL JOURNAL (2019)
Niclosamide ethanolamine induces trachea relaxation and inhibits proliferation and migration of trachea smooth muscle cells
Yuan-Yuan Wei et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Formulation and evaluation of cyclodextrin complexes for improved anticancer activity of repurposed drug: Niclosamide
Anurag Lodagekar et al.
CARBOHYDRATE POLYMERS (2019)
Contributions of Hepatic and Intestinal Metabolism to the Disposition of Niclosamide, a Repurposed Drug with Poor Bioavailability
Xiaoyu Fan et al.
DRUG METABOLISM AND DISPOSITION (2019)
Dual activity of niclosamide to suppress replication of integrated HIV-1 and Mycobacterium tuberculosis (Beijing)
XiuZhen Fan et al.
TUBERCULOSIS (2019)
Nanoliposomal Encapsulation Enhances In Vivo Anti-Tumor Activity of Niclosamide against Melanoma
Mahdi Hatamipour et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2019)
Repositioning of niclosamide ethanolamine (NEN), an anthelmintic drug, for the treatment of lipotoxicity
Jeong Su Park et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Effective and new potent drug combination: Histone deacetylase and Wnt/β-catenin pathway inhibitors in lung carcinoma cells
Oguzhan Akgun et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Targeting mTOR for cancer therapy
Hui Hua et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Niclosamide repositioning for treating cancer: Challenges and nano-based drug delivery opportunities
Eduardo Jose Barbosa et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer
Fan Luo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Dodecyl-TPP Targets Mitochondria and Potently Eradicates Cancer Stem Cells (CSCs): Synergy With FDA-Approved Drugs and Natural Compounds (Vitamin C and Berberine)
Ernestina Marianna De Francesco et al.
FRONTIERS IN ONCOLOGY (2019)
Cancer and the Immune System: The History and Background of Immunotherapy
Maura Abbott et al.
SEMINARS IN ONCOLOGY NURSING (2019)
Repurposing of the anti-helminthic drug niclosamide to treat melanoma and pulmonary metastasis via the STAT3 signaling pathway
Yongxia Zhu et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Niclosamide reverses adipocyte induced epithelial-mesenchymal transition in breast cancer cells via suppression of the interleukin-6/STAT3 signalling axis
Jones Gyamfi et al.
SCIENTIFIC REPORTS (2019)
Control of invasive sea lampreys using the piscicides TFM and niclosamide: Toxicology, successes & future prospects
Michael P. Wilkie et al.
AQUATIC TOXICOLOGY (2019)
Mitochondrial dynamics and metastasis
Dario C. Altieri
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Inhibition of LEF1-Mediated DCLK1 by Niclosamide Attenuates Colorectal Cancer Stemness
So-Yeon Park et al.
CLINICAL CANCER RESEARCH (2019)
The Anti-Rheumatoid Activity of Niclosamide in Collagen-induced Arthritis in Rats
Ali Al-Gareeb et al.
ARCHIVES OF RHEUMATOLOGY (2019)
Niclosamide piperazine prevents high-fat diet-induced obesity and diabetic symptoms in mice
Jingjing Guo et al.
EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY (2019)
Niclosamide suppresses acute myeloid leukemia cell proliferation through inhibition of CREB-dependent signaling pathways
Hee-Don Chae et al.
ONCOTARGET (2018)
Overexpression of ALK4 inhibits cell proliferation and migration through the inactivation of JAK/STAT3 signaling pathway in glioma
Chaojun Song et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Niclosamide, an oral antihelmintic drug, exhibits antimetastatic activity in hepatocellular carcinoma cells through downregulating twist-mediated CD10 expression
Ming-Hsien Chien et al.
ENVIRONMENTAL TOXICOLOGY (2018)
Octenylsuccinate hydroxypropyl phytoglycogen enhances the solubility and in-vitro antitumor efficacy of niclosamide
Ying Xie et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Anthelmintic niclosamide suppresses transcription of BCR-ABL fusion oncogene via disabling Sp1 and induces apoptosis in imatinib-resistant CML cells harboring T315I mutant
Bei Jin et al.
CELL DEATH & DISEASE (2018)
Effect of mitochondrial uncouplers niclosamide ethanolamine (NEN) and oxyclozanide on hepatic metastasis of colon cancer
Amer Alasadi et al.
CELL DEATH & DISEASE (2018)
Niclosamide sensitizes nasopharyngeal carcinoma to radiation by downregulating Ku70/80 expression
Jingjing Li et al.
JOURNAL OF CANCER (2018)
Niclosamide rescues microcephaly in a humanized in vivo model of Zika infection using human induced neural stem cells
Dana M. Cairns et al.
BIOLOGY OPEN (2018)
Niclosamide ethanolamine improves kidney injury in db/db mice
Pengxun Han et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer (vol 13, e0198389, 2018)
Michael T. Schweizer et al.
PLOS ONE (2018)
Bioenergetic modulation with the mitochondria uncouplers SR4 and niclosamide prevents proliferation and growth of treatment-naïve and vemurafenib-resistant melanomas
James L. Figarola et al.
Oncotarget (2018)
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robert W. Robey et al.
NATURE REVIEWS CANCER (2018)
Niclosamide Inhibits Cell Growth and Enhances Drug Sensitivity of Hepatocellular Carcinoma Cells via STAT3 Signaling Pathway
Chengzhi Wang et al.
JOURNAL OF CANCER (2018)
Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling
Bin Chen et al.
GASTROENTEROLOGY (2017)
Design, synthesis and characterization of poly (methacrylic acid-niclosamide) and its effect on arterial function
Rui Ma et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2017)
Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer
Chengfei Liu et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Niclosamide-conjugated polypeptide nanoparticles inhibit Wnt signaling and colon cancer growth
Jayanta Bhattacharyya et al.
NANOSCALE (2017)
Niclosamide ethanolamine inhibits artery constriction
Shan-Liang Li et al.
PHARMACOLOGICAL RESEARCH (2017)
Drug Repurposing of the Anthelmintic Niclosamide to Treat Multidrug-Resistant Leukemia
Sami Hamdoun et al.
FRONTIERS IN PHARMACOLOGY (2017)
Niclosamide: Beyond an antihelminthic drug
Wei Chen et al.
CELLULAR SIGNALLING (2017)
Niclosamide reduces glucagon sensitivity via hepatic PKA inhibition in obese mice: Implications for glucose metabolism improvements in type 2 diabetes
Md. Kamrul Hasan Chowdhury et al.
SCIENTIFIC REPORTS (2017)
Targeting of cell cycle and let-7a/STAT3 pathway by niclosamide inhibits proliferation, migration and invasion in oral squamous cell carcinoma cells
Xiaoxu Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Niclosamide induces apoptosis through mitochondrial intrinsic pathway and inhibits migration and invasion in human thyroid cancer in vitro
Kai Yu et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Niclosamide inhibits lytic replication of Epstein-Barr virus by disrupting mTOR activation
Lu Huang et al.
ANTIVIRAL RESEARCH (2017)
Metabolism of the anthelmintic drug niclosamide by cytochrome P450 enzymes and UDP-glucuronosyltransferases: metabolite elucidation and main contributions from CYP1A2 and UGT1A1
Danyi Lu et al.
XENOBIOTICA (2016)
Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission
Yu-Ming Wang et al.
ANTIVIRAL RESEARCH (2016)
Niclosamide induces apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes
Mingcheng Huang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Niclosamide inhibits colon cancer progression through downregulation of the Notch pathway and upregulation of the tumor suppressor miR-200 family
Mohammed A. Suliman et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
Niclosamide Prevents Systemic Sclerosis in a Reactive Oxygen Species-Induced Mouse Model
Florence Morin et al.
JOURNAL OF IMMUNOLOGY (2016)
Improvement of Sclerodermatous Graft-Versus-Host Disease in Mice by Niclosamide
Florence Morin et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen
Miao Xu et al.
NATURE MEDICINE (2016)
Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer
Chi-Kang Lin et al.
ONCOTARGET (2016)
S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide
Rachel L. Stewart et al.
ONCOTARGET (2016)
Niclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancer
Chengfei Liu et al.
ONCOTARGET (2016)
Niclosamide inhibits the inflammatory and angiogenic activation of human umbilical vein endothelial cells
Mingcheng Huang et al.
INFLAMMATION RESEARCH (2015)
Inhibitory effects of niclosamide on inflammation and migration of fibroblast-like synoviocytes from patients with rheumatoid arthritis
Liuqin Liang et al.
INFLAMMATION RESEARCH (2015)
Three-Dimensional Cell Culture-Based Screening Identifies the Anthelmintic Drug Nitazoxanide as a Candidate for Treatment of Colorectal Cancer
Wojciech Senkowski et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Niclosamide Suppresses Cell Migration and Invasion in Enzalutamide Resistant Prostate Cancer Cells via Stat3-AR Axis Inhibition
Chengfei Liu et al.
PROSTATE (2015)
Design and evaluation of injectable niclosamide nanocrystals prepared by wet media milling technique
Yanghuan Ye et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2015)
Repurposing Salicylanilide Anthelmintic Drugs to Combat Drug Resistant Staphylococcus aureus
Rajmohan Rajamuthiah et al.
PLOS ONE (2015)
Androgen receptor signaling in prostate cancer
Zoran Culig et al.
CANCER AND METASTASIS REVIEWS (2014)
Multi-targeted therapy of cancer by niclosamide: A new application for an old drug
Yonghe Li et al.
CANCER LETTERS (2014)
Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer
Chengfei Liu et al.
CLINICAL CANCER RESEARCH (2014)
Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice
Hanlin Tao et al.
NATURE MEDICINE (2014)
Drug Screening Identifies Niclosamide as an Inhibitor of Breast Cancer Stem-Like Cells
Yu-Chi Wang et al.
PLOS ONE (2013)
Identification of Three Antiviral Inhibitors against Japanese Encephalitis Virus from Library of Pharmacologically Active Compounds 1280
Jin'e Fang et al.
PLOS ONE (2013)
Niclosamide Is a Proton Carrier and Targets Acidic Endosomes with Broad Antiviral Effects
Andreas Jurgeit et al.
PLOS PATHOGENS (2012)
Niclosamide, an old antihelminthic agent, demonstrates antitumor activity by blocking multiple signaling pathways of cancer stem cells
Jing-Xuan Pan et al.
CHINESE JOURNAL OF CANCER (2012)
Thiazolides as Novel Antiviral Agents. 1. Inhibition of Hepatitis B Virus Replication
Andrew V. Stachulski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain production
F. L. Khanim et al.
BLOOD CANCER JOURNAL (2011)
Antineoplastic Mechanisms of Niclosamide in Acute Myelogenous Leukemia Stem Cells: Inactivation of the NF-κB Pathway and Generation of Reactive Oxygen Species
Yanli Jin et al.
CANCER RESEARCH (2010)
Identification of Niclosamide as a New Small-Molecule Inhibitor of the STAT3 Signaling Pathway
Xiaomei Ren et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
The Anti-Helminthic Niclosamide Inhibits Wnt/Frizzled1 Signaling
Minyong Chen et al.
BIOCHEMISTRY (2009)
Quantitative high-throughput screening identifies inhibitors of anthrax-induced cell death
Ping Jun Zhu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
The Autonomous Notch Signal Pathway Is Activated by Baicalin and Baicalein But Is Suppressed by Niclosamide in K562 Cells
An-Ming Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Screen for Chemical Modulators of Autophagy Reveals Novel Therapeutic Inhibitors of mTORC1 Signaling
Aruna D. Balgi et al.
PLOS ONE (2009)
Signal integration by JNK and p38 MAPK pathways in cancer development
Erwin F. Wagner et al.
NATURE REVIEWS CANCER (2009)
The MAPK signalling pathways and colorectal cancer
JY Fang et al.
LANCET ONCOLOGY (2005)
Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide
CJ Wu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
分享论文
